08045804946
Send Inquiry
VIVITRA 150MG
3000.0 INR/Number
Product Details:
- Packaging Type Glass Vial
- Dosage Form Injection
- Life Span 24 Months from manufacturing
- Origin of Medicine India
- Pacakaging (Quantity Per Box) 1 Vial per Box
- Indication Treatment of HER2-positive breast and gastric cancer
- Brand Name VIVITRA 150MG
- Click to View more
X
VIVITRA 150MG Price And Quantity
- 3000.0 INR/Number
- 1 Number
- Monoclonal Antibody
- Hospital/Clinical Use
- Prescription Only
- Reconstitute with provided sterile water before use
- Fever, chills, cardiac dysfunction, infusion reactions
- L01XC03
- Intravenous Infusion
- 24 Months
- Adults only
- Use under medical supervision only; monitor for infusion-related reactions
- Known hypersensitivity to trastuzumab or any excipients
VIVITRA 150MG Product Specifications
- 1 Vial per Box
- Trastuzumab Lyophilized Powder
- Treatment of HER2-positive breast and gastric cancer
- As directed by the oncologist, reconstitute before use.
- Biological
- 150 mg per vial
- Antineoplastic (anti-cancer)
- HER2-positive breast cancer, metastatic gastric cancer
- Lyophilized Powder for Injection
- Trastuzumab 150mg
- VIVITRA 150MG
- 1 Vial
- Store at 2C - 8C in a refrigerator. Do not freeze.
- Glass Vial
- Injection
- India
- 24 Months from manufacturing
- Adults
- Monoclonal Antibody
- Hospital/Clinical Use
- Prescription Only
- Reconstitute with provided sterile water before use
- Fever, chills, cardiac dysfunction, infusion reactions
- L01XC03
- Intravenous Infusion
- 24 Months
- Adults only
- Use under medical supervision only; monitor for infusion-related reactions
- Known hypersensitivity to trastuzumab or any excipients
VIVITRA 150MG Trade Information
- 1000 Number Per Week
- 2 Days
- No
- Eastern Europe, Western Europe, Middle East, Asia, Australia, Central America, North America, South America, Africa
- All India
Product Description
Trastuzumab is a recombinant IgG1 monoclonal antibody that works by selectively binding to the HER2 proteins on the surface of cancer cells. This binding action performs two main functions:
- Inhibits cell growth:It blocks the signals that tell the cancer cells to grow and multiply rapidly.
- Activates the immune system:It helps the body's immune system to recognize and destroy the cancerous cells.
This targeted approach minimizes the impact on healthy cells compared to traditional chemotherapy.
Key Uses
Vivitra 150 mg is indicated for the treatment of:
- Early-stage breast cancer(following surgery, chemotherapy, and potentially radiotherapy in applicable cases).
- Metastatic breast cancer(cancer that has spread to other parts of the body).
- Metastatic gastric (stomach) canceror gastroesophageal junction adenocarcinoma.
It can be used alone (monotherapy) or in combination with other anti-cancer treatments like chemotherapy or hormonal therapy, as determined by a healthcare professional.
Administration and Dosage
Vivitra 150 mg is administered by a qualified healthcare professional, usually in a hospital or clinic setting, as an intravenous (IV) infusion or a subcutaneous injection. It is not for self-administration.
- The initial dose is typically infused slowly over 90 minutes.
- Subsequent maintenance doses, if well-tolerated, may be given over 30 minutes.
- Dosage and frequency depend on the patient's condition, weight, and response to treatment.
Important Safety Information
- Heart Problems:Vivitra can cause serious heart problems, including congestive heart failure. Regular monitoring of heart function is essential before, during, and after treatment.
- Pregnancy/Breastfeeding:The medication is not recommended during pregnancy or breastfeeding, as it can harm the fetus or baby. Effective contraception is required during treatment and for at least 7 months after the final dose.
- Infusion Reactions/Lung Damage:Serious infusion reactions and lung damage can occur. Patients are monitored closely during and after administration for symptoms like difficulty breathing, fever, or chills.
- Blood Cell Counts:It can lower blood cell counts, increasing the risk of infection. Regular blood tests are necessary.
Common Side Effects
Common side effects may include nausea, headache, rash, insomnia, infections, diarrhea, and fatigue. Patients should consult their doctor if side effects are persistent or severe.
Effective Therapy for HER2-Positive Cancers
VIVITRA 150MG offers targeted treatment for adults diagnosed with HER2-positive breast or metastatic gastric cancer. Its monoclonal antibody action inhibits cancer cell proliferation, supporting improved clinical outcomes when used as part of a comprehensive oncology regimen. As a leading biological therapy, it plays a crucial role in modern cancer care.
Safe Administration and Monitoring
Hospital or clinical usage is required for VIVITRA 150MG due to its potential for infusion-related reactions. Infusions are performed by medical professionals following reconstitution with sterile water. Continuous patient monitoring, especially for cardiac function and initial infusion reactions, ensures both safety and treatment efficacy during administration.
FAQ's of VIVITRA 150MG:
Q: How is VIVITRA 150MG prepared and administered?
A: VIVITRA 150MG must be reconstituted with the sterile water provided, then administered as an intravenous infusion. This preparation and administration should only be performed by healthcare professionals in a hospital or clinical setting.Q: What conditions does VIVITRA 150MG treat?
A: This medication is recommended for adults with HER2-positive breast cancer and metastatic gastric cancer. Its active ingredient, trastuzumab, is specifically designed to target HER2-positive cancer cells.Q: When should VIVITRA 150MG be used during cancer treatment?
A: The timing and frequency of VIVITRA 150MG infusions are determined by an oncologist based on individual treatment plans. It is a key component in regimens for HER2-positive breast or gastric cancer and should only be used as prescribed.Q: Where should VIVITRA 150MG be stored to maintain efficacy?
A: Store VIVITRA 150MG refrigerated between 2C and 8C. Do not freeze, and always keep the product in its original packaging until ready for reconstitution and administration.Q: What precautions should be taken when using VIVITRA 150MG?
A: Use VIVITRA 150MG strictly under medical supervision. Monitor for infusion-related reactions and cardiac dysfunction. It is contraindicated in patients with known hypersensitivity to trastuzumab or any of its excipients.Q: What are the common side effects of VIVITRA 150MG?
A: Patients may experience fever, chills, infusion reactions, or cardiac dysfunction. Promptly report any unusual symptoms to the attending healthcare team during and after the infusion process.Q: What are the primary benefits of VIVITRA 150MG?
A: VIVITRA 150MG provides targeted, effective therapy for HER2-positive cancers, helping to inhibit tumor growth and improve treatment outcomes in eligible adult patients.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
